OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Murphy, Margaret Moline, David Mayleben, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 11, pp. 1289-1299
Open Access | Times Cited: 298
Patricia Murphy, Margaret Moline, David Mayleben, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 11, pp. 1289-1299
Open Access | Times Cited: 298
Showing 26-50 of 298 citing articles:
Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.
Andrew S. Huhn, Patrick H. Finan
Experimental and Clinical Psychopharmacology (2021) Vol. 30, Iss. 6, pp. 1024-1035
Open Access | Times Cited: 38
Andrew S. Huhn, Patrick H. Finan
Experimental and Clinical Psychopharmacology (2021) Vol. 30, Iss. 6, pp. 1024-1035
Open Access | Times Cited: 38
Common Sleep Disorders Affecting Older Adults
Ecler Jaqua, Mary Hanna, Wessam Labib, et al.
The Permanente Journal (2022) Vol. 27, Iss. 1, pp. 122-132
Open Access | Times Cited: 23
Ecler Jaqua, Mary Hanna, Wessam Labib, et al.
The Permanente Journal (2022) Vol. 27, Iss. 1, pp. 122-132
Open Access | Times Cited: 23
The Black Book of Psychotropic Dosing and Monitoring.
Charles DeBattista, Alan F. Schatzberg
PubMed (2024) Vol. 54, Iss. 3, pp. 8-59
Closed Access | Times Cited: 5
Charles DeBattista, Alan F. Schatzberg
PubMed (2024) Vol. 54, Iss. 3, pp. 8-59
Closed Access | Times Cited: 5
The interaction between orexin, sleep deprivation and Alzheimer’s disease: Unveiling an Emerging Connection
Masoumeh Kourosh‐Arami, Mahdi Ramezani, Alireza Komaki
The Journal of Physiological Sciences (2025) Vol. 75, Iss. 1, pp. 100004-100004
Open Access
Masoumeh Kourosh‐Arami, Mahdi Ramezani, Alireza Komaki
The Journal of Physiological Sciences (2025) Vol. 75, Iss. 1, pp. 100004-100004
Open Access
Navigating the evolving landscape in the prescribing of medications for insomnia in Singapore: Principles and considerations from a psychiatrist’s perspective
Ho Teck Tan, Chao Tian Tang, Shian Ming Tan
Annals of the Academy of Medicine Singapore (2025) Vol. 54, Iss. 1, pp. 53-56
Open Access
Ho Teck Tan, Chao Tian Tang, Shian Ming Tan
Annals of the Academy of Medicine Singapore (2025) Vol. 54, Iss. 1, pp. 53-56
Open Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Analysis of sleep medication‐induced parasomnias using the Japanese Adverse Drug Event Report database
Shotaro Kobayashi, Koji Shinozaki, Hiroyuki Nagano, et al.
Journal of Sleep Research (2025)
Open Access
Shotaro Kobayashi, Koji Shinozaki, Hiroyuki Nagano, et al.
Journal of Sleep Research (2025)
Open Access
Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Efficacy and safety of Lemborexant in treating adult patients with insomnia in China: a single-center, retrospective observational study
Weiying Jian, Minyan Feng, Yifan Zhao, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Weiying Jian, Minyan Feng, Yifan Zhao, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
Carsten T. Beuckmann, Takashi Ueno, Makoto Nakagawa, et al.
SLEEP (2019) Vol. 42, Iss. 6
Open Access | Times Cited: 38
Carsten T. Beuckmann, Takashi Ueno, Makoto Nakagawa, et al.
SLEEP (2019) Vol. 42, Iss. 6
Open Access | Times Cited: 38
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders
Christoph Boss, John Gatfield, Christine Brotschi, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2286-2305
Closed Access | Times Cited: 37
Christoph Boss, John Gatfield, Christine Brotschi, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2286-2305
Closed Access | Times Cited: 37
Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials
Margaret Moline, Gary Zammit, Jane Yardley, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 1, pp. 71-81
Open Access | Times Cited: 36
Margaret Moline, Gary Zammit, Jane Yardley, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 1, pp. 71-81
Open Access | Times Cited: 36
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis
Heather McElroy, Beth O’Leary, Michael Adena, et al.
Journal of Managed Care & Specialty Pharmacy (2021) Vol. 27, Iss. 9, pp. 1296-1308
Open Access | Times Cited: 28
Heather McElroy, Beth O’Leary, Michael Adena, et al.
Journal of Managed Care & Specialty Pharmacy (2021) Vol. 27, Iss. 9, pp. 1296-1308
Open Access | Times Cited: 28
Reversal of Regioselectivity in Nucleophilic Difluoroalkylation of α,β-Enones Employing In Situ-Formed Sterically Encumbered Silylium Catalyst
Jinshan Li, Saimei Liu, Rong Zhong, et al.
Organic Letters (2021) Vol. 23, Iss. 15, pp. 5859-5864
Closed Access | Times Cited: 28
Jinshan Li, Saimei Liu, Rong Zhong, et al.
Organic Letters (2021) Vol. 23, Iss. 15, pp. 5859-5864
Closed Access | Times Cited: 28
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials
Feiyu Jiang, Hang Li, Yanting Chen, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32754-e32754
Open Access | Times Cited: 12
Feiyu Jiang, Hang Li, Yanting Chen, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32754-e32754
Open Access | Times Cited: 12
The Underlying Mechanisms of Sleep Deprivation Exacerbating Neuropathic Pain
Manmin Zhu, Hao Huang
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 579-591
Open Access | Times Cited: 12
Manmin Zhu, Hao Huang
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 579-591
Open Access | Times Cited: 12
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
A decade of pyridine containing heterocycles in the approved USFDA drugs: A medicinal chemistry-based analysis
Ashish Ranjan Dwivedi, Shivani Jaiswal, Deepak Kukkar, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 4
Ashish Ranjan Dwivedi, Shivani Jaiswal, Deepak Kukkar, et al.
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 4
Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review
Aisha S. Shariq, Joshua D. Rosenblat, Asem Alageel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 92, pp. 1-7
Closed Access | Times Cited: 36
Aisha S. Shariq, Joshua D. Rosenblat, Asem Alageel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 92, pp. 1-7
Closed Access | Times Cited: 36
Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice
Carrie E. Mahoney, Takatoshi Mochizuki, Thomas E. Scammell
SLEEP (2019) Vol. 43, Iss. 6
Open Access | Times Cited: 30
Carrie E. Mahoney, Takatoshi Mochizuki, Thomas E. Scammell
SLEEP (2019) Vol. 43, Iss. 6
Open Access | Times Cited: 30
